Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Infectious Diseases

    Many Children Hospitalized with COVID-19 or MIS-C Have Lingering Complications Months Later

    By Global Biodefense StaffAugust 12, 2022
    Sheri Flores, Pediatric Intensive Care Unit charge nurse, secures a pulse oximeter on patient, Margaret Moore. Photo: Jason W. Edwards
    Share
    Facebook LinkedIn Reddit Email

    National follow-up study identifies risk factors for a prolonged recovery

    In one of the largest follow-up studies to date, involving 25 pediatric hospitals, more than a quarter of children and adolescents hospitalized with coronavirus infection early in the pandemic still had health problems two to four months later, either persisting symptoms or activity impairment. The study, led by Boston Children’s Hospital, is published August 12 in the journal Pediatrics.

    As part of the national Overcoming COVID-19 study, investigators led by Adrienne Randolph, MD, MSc, of Boston Children’s surveyed family caregivers of patients under age 21 who were hospitalized with COVID-19 or multisystem inflammatory syndrome in children (MIS-C). The study period ran from May 2020 to May 2021, before vaccines were available. Of 358 patients, the researchers got survey responses for 279, or 78 percent.

    Of these children and youth, roughly 40 percent were hospitalized with acute COVID-19 and roughly 60 percent with MIS-C. Fifty percent and 86 percent, respectively, were admitted to the intensive care unit.

    At two- to four-month follow up, 27 percent of patients with acute COVID-19 and 30 percent of those with MIS-C had persistent symptoms, activity impairment, or both.

    “Almost three quarters were back to baseline, which is reassuring,” says Randolph. “But unfortunately, more than one in four were not. Although this is much better than many reports in hospitalized older adults, it is still very worrisome. The risks of severe illness and lingering complications are higher than the risk of complications from the vaccine, which are very rare.”

    Of the children and adolescents with lingering symptoms, the most common symptoms were:

    • fatigue or weakness, affecting 11.3 percent of those with COVID-19 and 20 percent of those with MIS-C
    • shortness of breath (9.2 percent and 2.5 percent, respectively)
    • cough (9.2 and 2.5 percent)
    • headache (8.4 and 7.5 percent)
    • muscle and body aches (5 and 3.1 percent)
    • fever (2.5 and 0.6 percent).

    Activity impairment was somewhat more common after MIS-C (affecting 21.3 percent) than after acute COVID-19 (14.3 percent). According to caregiver reports:

    • 6.7 percent of the COVID-19 group and 14.4 percent of the MIS-C group could not walk or exercise as much as before.
    • 6.7 and 7.5 percent, respectively, were sleeping much more than usual.
    • 4.2 and 3.8 percent, respectively, had difficulty getting schoolwork done or felt distracted and unable to focus.

    Three factors predicted an increased risk for a prolonged recovery or activity impairment:

    • more organ system involvement in patients with acute COVID-19
    • underlying respiratory conditions (usually asthma) in patients with MIS-C
    • obesity in patients with MIS-C.

    Randolph notes that this study was limited to children and adolescents who needed to be admitted to the hospital, and that it took place early in the pandemic; most were admitted before the Delta surge.

    “We’re in the process of analyzing more recent data covering the Delta period and part of the Omicron period, including effects on health-related quality of life,” Randolph says. “I think it’s possible there will be differences. It’s important to understand how all the different variants affect children and to track how effective vaccination is in preventing long-term complications.”

    Ongoing investigations led by Boston Children’s are also looking at neurologic complications of acute COVID-19 and MIS-C using detailed neurocognitive testing, Randolph says.

    “Now that vaccines are available, I strongly recommend that children and adolescents get vaccinated,” she says. “We know that patients can be re-infected even if they’ve had COVID-19, and we previously showed that vaccination can prevent MIS-C and severe COVID-19.”

    Source: Boston Children’s Hospital, adapted

    COVID-19 Epidemiology Long COVID Pediatric Infectious Diseases SARS-CoV-2
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleChildren Infected with a Mild Case of COVID-19 Can Still Develop Long COVID Symptoms
    Next Article UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

    Related Stories

    Valley Fever: An Invisible Killer Expands Its Range in the American West

    November 17, 2023

    COVID Moonshot Consortium Announces Crowd-Sourced Small Molecule Discovery

    November 11, 2023

    WHO Updates Guidance on Treatments for COVID-19

    November 11, 2023

    The Latest Mpox Outbreak Numbers in the UK

    November 3, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.